Abstract 101: Cost-Effectiveness and Decision Analysis of Polygenic Risk Scores in Statin Use for Primary Prevention [Session Title: Poster Session AM]

Conclusions: Genomic testing to improve statin use is cost-effective for a very large number of Americans at current prices.

Source: Circulation: Cardiovascular Quality and Outcomes - April 5, 2018 Category: Cardiology Authors: Sussman, J., Marrero, W., Burke, J., Lavieri, M., Hayward, R. A. Tags: Session Title: Poster Session AM Source Type: research